SELLAS Stock Up 346% in a Year as Cancer Vaccine Trial Nears Its Final 8 Deaths [Yahoo! Finance]
SELLAS Life Sciences Group, Inc. (SLS)
Last sellas life sciences group, inc. earnings: 11/14 04:41 pm
Check Earnings Report
US:NYSE Investor Relations:
sellaslifesciences.com/investors/overview/default.aspx
Company Research
Source: Yahoo! Finance
REGAL trial for GPS, a WT1-targeting cancer vaccine in AML patients, approaches completion with 72 of 80 required patient deaths recorded, with only 12 deaths among 66 at-risk patients suggesting lower-than-expected mortality and a potential cure-fraction population. The trial's slower-than-expected death rate is being interpreted as bullish evidence that GPS extends long-term survival in acute myeloid leukemia patients, with institutional ownership surging to 171+ institutions and the IDMC clearing the trial twice without modification. A recent study identified one single habit that doubled Americans' retirement savings and moved retirement from dream, to reality. Read more here A late-stage clinical biopharmaceutical company focused on immunotherapy for various cancers, SELLAS Life Sciences Group ( NASDAQ:SLS ) is at a genuinely unusual inflection point. Its shares have climbed 346% over the past year, yet the stock pulled back 13.4% in the past week to $5.04, with Q4 earnin
Show less
Read more
Impact Snapshot
Event Time:
SLS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SLS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SLS alerts
High impacting SELLAS Life Sciences Group, Inc. news events
Weekly update
A roundup of the hottest topics
SLS
News
- Assessing SELLAS Life Sciences Group (SLS) Valuation After Its Sharp Recent Share Price Run [Yahoo! Finance]Yahoo! Finance
- SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- SELLAS Life Sciences GAAP EPS of -$0.25 beats by $0.01 [Seeking Alpha]Seeking Alpha
- SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate UpdateGlobeNewswire
- SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference [Yahoo! Finance]Yahoo! Finance
SLS
Sec Filings
- 3/20/26 - Form S-3ASR
- 3/19/26 - Form 8-K
- 3/19/26 - Form 10-K
- SLS's page on the SEC website